rs145148929
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_182919.4(TICAM1):c.479C>T(p.Ser160Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00258 in 1,613,908 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 4 hom. )
Consequence
TICAM1
NM_182919.4 missense
NM_182919.4 missense
Scores
5
7
Clinical Significance
Conservation
PhyloP100: 5.35
Genes affected
TICAM1 (HGNC:18348): (TIR domain containing adaptor molecule 1) This gene encodes an adaptor protein containing a Toll/interleukin-1 receptor (TIR) homology domain, which is an intracellular signaling domain that mediates protein-protein interactions between the Toll-like receptors (TLRs) and signal-transduction components. This protein is involved in native immunity against invading pathogens. It specifically interacts with toll-like receptor 3, but not with other TLRs, and this association mediates dsRNA induction of interferon-beta through activation of nuclear factor kappa-B, during an antiviral immune response. Mutations in this gene are associated with encephalopathy, acute, infection-induced. [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0064916313).
BP6
Variant 19-4817899-G-A is Benign according to our data. Variant chr19-4817899-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 473295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 4 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TICAM1 | NM_182919.4 | c.479C>T | p.Ser160Phe | missense_variant | 2/2 | ENST00000248244.6 | |
TICAM1 | NM_001385678.1 | c.437C>T | p.Ser146Phe | missense_variant | 3/3 | ||
TICAM1 | NM_001385679.1 | c.344C>T | p.Ser115Phe | missense_variant | 2/2 | ||
TICAM1 | NM_001385680.1 | c.-71-93C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TICAM1 | ENST00000248244.6 | c.479C>T | p.Ser160Phe | missense_variant | 2/2 | 1 | NM_182919.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00219 AC: 334AN: 152196Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
334
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00219 AC: 544AN: 248930Hom.: 1 AF XY: 0.00221 AC XY: 298AN XY: 134742
GnomAD3 exomes
AF:
AC:
544
AN:
248930
Hom.:
AF XY:
AC XY:
298
AN XY:
134742
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00262 AC: 3827AN: 1461594Hom.: 4 Cov.: 82 AF XY: 0.00255 AC XY: 1852AN XY: 727092
GnomAD4 exome
AF:
AC:
3827
AN:
1461594
Hom.:
Cov.:
82
AF XY:
AC XY:
1852
AN XY:
727092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00219 AC: 334AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.00197 AC XY: 147AN XY: 74484
GnomAD4 genome
AF:
AC:
334
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
147
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
8
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
30
ExAC
AF:
AC:
293
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | TICAM1: BP4, BS2 - |
Herpes simplex encephalitis, susceptibility to, 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MutationTaster
Benign
N
Sift4G
Benign
T
Vest4
MVP
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at